Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

The Lancet Neurology - Tập 17 Số 2 - Trang 162-173 - 2018
Alan J. Thompson1, Brenda Banwell2, Frederik Barkhof3,4,5, William M. Carroll6, Timothy Coetzee7, Giancarlo Comi8, Jorge Correale9, Franz Fazekas10, Massimo Filippi11, Mark S. Freedman12, Kazuo Fujihara13,14, Steven Galetta15, Hans-Peter Hartung16, Ludwig Kappos17, Fred Lublin18, Ruth Ann Marrie19, Aaron E. Miller18, David H. Miller20, Xavier Montalbán21,22, Ellen M. Mowry23, Per Soelberg Sørensen24, Mar Tintoré21, Anthony Traboulsee25, Maria Trojano26, Bernard M.J. Uitdehaag27, Junqian Xu28,29,30, Emmanuelle Waubant31, Brian G. Weinshenker32, Stephen L. Hauser33, Jeffrey A. Cohen34
1Faculty of Brain Sciences, University College London, London, UK
2Division of Neurology, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
3Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, Netherlands
4Institute of Healthcare Engineering, University College London, London, UK
5Institute of Neurology, University College London, London, UK
6Neurology Department, Sir Charles Gairdner Hospital, Perth, WA, Australia
7National Multiple Sclerosis Society, New York, NY, USA
8Department of Neurology, Vita-Salute San Raffaele University-Ospedale San Raffaele, Milan, Italy
9Institute for Neurological Research Dr. Raúl Carrea FLENI, Buenos Aires, Argentina
10Department of Neurology, Medical University of Graz, Graz, Austria
11The Neuroimaging Research Unit, San Raffaele Scientific Institute, Vita-Salute San Raffaele University-Ospedale San Raffaele, Milan, Italy
12Department of Medicine, The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada
13Department of Multiple Sclerosis Therapeutics, School of Medicine, Fukushima Medical University, Fukushima, Japan
14Multiple Sclerosis and Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience, Koriyama, Fukushima, Japan
15Department of Neurology, New York University Langone Medical Center, New York, NY, USA
16Department of Neurology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany
17Neurologic Clinic and Policlinic, Departments of Medicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland
18Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Icahn School of Medicine at Mount Sinai, New York, NY, USA
19Departments of Internal Medicine and Community Health Sciences, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada
20Queen Square Multiple Sclerosis Centre, University College London, London, UK
21Centre d'Esclerosi Múltiple de Catalunya, Vall d'Hebron University Hospital, Barcelona, Spain
22Division of Neurology, University of Toronto, St Michael's Hospital, Toronto, ON, Canada
23Department of Neurology, Johns Hopkins University, Baltimore, MD USA
24Danish Multiple Sclerosis Center, University of Copenhagen–Rigshospitalet, Copenhagen, Denmark
25Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada
26Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Bari, Italy
27Department of Neurology, VU University Medical Center, Amsterdam, Netherlands
28Centre des Neurosciences de Lyon, INSERM 1028 et CNRS UMR5292, Lyon, France
29Service de neurologie, Sclérose en Plaques, Pathologies de la Myéline et Neuro-inflammation, Hôpital Neurologique, Hospices Civils de Lyon, Bron, France
30Université Claude Bernard Lyon 1, Faculté de Médecine Lyon-Est, Villeurbanne, Auvergne-Rhône-Alpes, France
31Department of Neurology, University of California at San Francisco, San Francisco, CA, USA
32Department of Neurology, Mayo Clinic, Rochester, MN, USA
33Scientific and Clinical Review Associates LLC, Salisbury, CT, USA
34Neurologic Institute, Cleveland Clinic, Cleveland, OH, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Schumacher, 1965, Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis, Ann NY Acad Sci, 122, 552, 10.1111/j.1749-6632.1965.tb20235.x

Poser, 1983, New diagnostic criteria for multiple sclerosis: guidelines for research protocols, Ann Neurol, 13, 227, 10.1002/ana.410130302

McDonald, 2001, Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis, Ann Neurol, 50, 121, 10.1002/ana.1032

Polman, 2005, Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”, Ann Neurol, 58, 840, 10.1002/ana.20703

Polman, 2011, Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald Criteria, Ann Neurol, 69, 292, 10.1002/ana.22366

Brownlee, 2016, Multiple Sclerosis 1. Diagnosis of multiple sclerosis: progress and challenges, Lancet, 389, 1336, 10.1016/S0140-6736(16)30959-X

Filippi, 2016, MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines, Lancet Neurol, 15, 292, 10.1016/S1474-4422(15)00393-2

Miller, 2005, Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis, Lancet Neurol, 4, 281, 10.1016/S1474-4422(05)70071-5

Miller, 2008, Differential diagnosis of suspected multiple sclerosis: a consensus approach, Mult Scler, 14, 1157, 10.1177/1352458508096878

Lublin, 2014, Defining the clinical course of multiple sclerosis: the 2013 revisions, Neurology, 83, 278, 10.1212/WNL.0000000000000560

Filippi, 2010, Intracortical lesions. Relevance for new MRI diagnostic criteria for multiple sclerosis, Neurology, 75, 1988, 10.1212/WNL.0b013e3181ff96f6

Preziosa, 2017, Diagnosis of multiple sclerosis: a multicentre study to compare revised McDonald-2010 and Filippi-2010 criteria, J Neurol Neurosurg Psychiatry

Aliaga, 2014, MRI mimics of multiple sclerosis, Handb Clin Neurol, 122, 291, 10.1016/B978-0-444-52001-2.00012-1

Rovira, 2015, MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process, Nat Rev Neurol, 11, 471, 10.1038/nrneurol.2015.106

Murray, 1984, Characteristics of patients found not to have multiple sclerosis, Can Med Assoc J, 131, 336

Poser, 1997, Misdiagnosis of multiple sclerosis and β-interferon, Lancet, 349, 1916, 10.1016/S0140-6736(05)63920-7

Carmosino, 2005, Initial evaluations for multiple sclerosis in a university multiple sclerosis center, Arch Neurol, 62, 585, 10.1001/archneur.62.4.585

Solomon, 2016, The contemporary spectrum of multiple sclerosis misdiagnosis: a multicenter study, Neurology, 87, 1393, 10.1212/WNL.0000000000003152

Solomon, 2017, The tension between early diagnosis and misdiagnosis in multiple sclerosis, Nat Rev Neurol, 13, 567, 10.1038/nrneurol.2017.106

Rudick, 1986, Multiple sclerosis. The problem of incorrect diagnosis, Arch Neurol, 43, 578, 10.1001/archneur.1986.00520060042015

Charil, 2006, MRI and the diagnosis of multiple sclerosis: expanding the concept of “no better explanation”, Lancet Neurol, 5, 841, 10.1016/S1474-4422(06)70572-5

Kang, 2014, Application and a proposed modification of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Canadian cohort of patients with clinically isolated syndromes, Mult Scler J, 20, 458, 10.1177/1352458513501230

D'Alessandro, 2013, Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective study, J Neurol, 260, 1583, 10.1007/s00415-013-6838-x

Runia, 2013, Application of the 2010 revised criteria for the diagnosis of multiple sclerosis to patients with clinically isolated syndromes, Eur J Neurol, 20, 1510, 10.1111/ene.12243

Gomez-Moreno, 2012, Application of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Spanish cohort of patients with clinicaly isolated syndromes, Mult Scler J, 18, 39, 10.1177/1352458511417828

Belova, 2014, Revised McDonald criteria for multiple sclerosis diagnostics in central Russia: sensitivity and specificity, Mult Scler J, 20, 1896, 10.1177/1352458514539405

Hsueh, 2013, Comparison of the 2010 and 2005 versions of the McDonald MRI criteria for dissemination-in-time in Taiwanese patients with classic multiple sclerosis, J Neurol Sci, 329, 51, 10.1016/j.jns.2013.03.018

Huh, 2014, Evaluation of McDonald MRI criteria for dissemination in space in Korean patients with clinically isolated syndromes, Mult Scler J, 20, 492, 10.1177/1352458513496881

Piccolo, 2015, Multiple sclerosis in Japan appears to be a milder disease compared to the UK, J Neurol, 262, 831, 10.1007/s00415-015-7637-3

Alroughani, 2012, Predictors of conversion to multiple sclerosis in patients with clinically isolated syndrome using the 2010 revised McDonald criteria, ISRN Neurol, 2012, 792192, 10.5402/2012/792192

Yamout, 2013, Consensus guidelines for the diagnosis and treatment of multiple sclerosis, Curr Med Res Opin, 29, 611, 10.1185/03007995.2013.787979

Patrucco, 2013, Application of the McDonald 2010 criteria for the diagnosis of multiple sclerosis in an Argentinean cohort of patients with clinically isolated syndromes, Mult Scler J, 10, 1297, 10.1177/1352458513475492

da Rocha, 2013, Central nervous system infectious diseases mimicking multiple sclerosis: recognizing distinguishable features using MRI, Arq Neuropsiquiatr, 71, 738, 10.1590/0004-282X20130162

Kornek, 2012, Evaluation of the 2010 McDonald multiple sclerosis criteria in children with a clinically isolated syndrome, Mult Scler J, 18, 1768, 10.1177/1352458512444661

Sadaka, 2012, 2010 McDonald Criteria for diagnosing pediatric multiple sclerosis, Ann Neurol, 72, 211, 10.1002/ana.23575

Sedani, 2012, Paediatric multiple sclerosis: examining utility of the McDonald 2010 criteria, Mult Scler J, 18, 679, 10.1177/1352458511426815

Bigi, 2013, 2010 McDonald criteria in a pediatric cohort: is positivity at onset associated with a more aggressive multiple sclerosis course?, Mult Scler J, 19, 1359, 10.1177/1352458513486519

Heussinger, 2013, Predicting multiple sclerosis following isolated optic neuritis in children, Eur J Neurol, 20, 1292, 10.1111/ene.12184

Hummel, 2013, Pediatric onset multiple sclerosis: McDonald criteria 2010 and the contribution of spinal cord MRI, Mult Scler J, 19, 1330, 10.1177/1352458513493033

Tantsis, 2013, Risk of multiple sclerosis after a first demyelinating syndrome in an Australian paediatric cohort: clinical, radiological features and application of the McDonald 2010 MRI criteria, Mult Scler J, 19, 1749, 10.1177/1352458513484377

Williams, 2014, Use of the 2010 McDonald criteria can facilitate early diagnosis in pediatric multiple sclerosis in a predominantly black cohort, Pediatr Neurol, 51, 826, 10.1016/j.pediatrneurol.2014.08.032

Pohl, 2016, Acute disseminated encephalomyelitis. Updates on an inflammatory CNS syndrome, Neurology, 87, S38, 10.1212/WNL.0000000000002825

Krupp, 2013, International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions, Mult Scler J, 19, 1261, 10.1177/1352458513484547

Rostasy, 2012, Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis, Arch Neurol, 69, 752, 10.1001/archneurol.2011.2956

Hacohen, 2015, Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children, Neurol Neuroimmunol Neuroinflamm, 2, e81, 10.1212/NXI.0000000000000081

Hacohen, 2017, Diagnostic algorithm for relapsing acquired demyelinating syndromes in children, Neurology, 89, 269, 10.1212/WNL.0000000000004117

Kis, 2008, Clinical characteristics of patients with late-onset multiple sclerosis, J Neurol, 255, 697, 10.1007/s00415-008-0778-x

Bermel, 2010, Diagnosing multiple sclerosis at a later age: more than just progressive myelopathy, Mult Scler J, 16, 1335, 10.1177/1352458510377334

Papadopoulos, 2014, Treatment of neuromyelitis optica: state-of-the-art and emerging therapies, Nat Rev Neurol, 10, 493, 10.1038/nrneurol.2014.141

Lennon, 2004, A serum antibody marker of neuromyelitis optica: distinction from multiple sclerosis, Lancet, 364, 2106, 10.1016/S0140-6736(04)17551-X

Lennon, 2005, IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel, J Exp Med, 202, 473, 10.1084/jem.20050304

Sato, 2014, Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders, Neurology, 82, 474, 10.1212/WNL.0000000000000101

Kaneko, 2016, Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies, J Neurol Neurosurg Psychiatry, 87, 1257, 10.1136/jnnp-2015-312676

Waters, 2015, MOG cell-based assay detects non-MS patients with inflammatory neurologic disease, Neurol Neuroimmunol Neuroinflamm, 2, e89, 10.1212/NXI.0000000000000089

Jarius, 2016, MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin, J Neuroinflammation, 13, 279, 10.1186/s12974-016-0717-1

Spadaro, 2016, Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis, Neurol Neuroimmunol Neuroinflamm, 3, e257, 10.1212/NXI.0000000000000257

Wingerchuk, 2015, International consensus diagnostic criteria for neuromyelitis optica spectrum disorders, Neurology, 85, 177, 10.1212/WNL.0000000000001729

Kimbrough, 2012, Treatment of neuromyelitis optica: review and recommendations, Mult Scler Relat Disord, 1, 180, 10.1016/j.msard.2012.06.002

Wattjes, 2015, Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—establishing disease prognosis and monitoring patients, Nat Rev Neurol, 11, 597, 10.1038/nrneurol.2015.157

Traboulsee, 2016, Revised recommendations of the Consortium of MS Centers task force for a standardized MRI protocol and clinical guidelines for the diagnosis and follow-up of multiple sclerosis, AJNR Am J Neuroradiology, 37, 394, 10.3174/ajnr.A4539

Arrambide, 2016, CSF examination still has value in the diagnosis of MS—commentary, Mult Scler J, 22, 997, 10.1177/1352458516642033

Andersson, 1994, Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report, J Neurol Neurosurg Psychiatry, 57, 897, 10.1136/jnnp.57.8.897

Stangel, 2013, The utility of cerebrospinal fluid analysis in patients with multiple sclerois, Nat Rev Neurol, 9, 267, 10.1038/nrneurol.2013.41

Freedman, 2005, Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement, Arch Neurol, 62, 865, 10.1001/archneur.62.6.865

Tintore, 2001, Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MRI criteria to predict conversion to CDMS, Mult Scler, 7, 359, 10.1177/135245850100700603

Tintore, 2008, Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?, Neurology, 70, 1079, 10.1212/01.wnl.0000280576.73609.c6

Andreadou, 2013, Prevalence of cerebrospinal fluid oligoclonal IgG bands in Greek patients with clinically isolated syndrome and multiple sclerosis, Clin Neurol Neurosurg, 115, 2094, 10.1016/j.clineuro.2013.07.026

Dobson, 2013, Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude, J Neurol Neurosurg Psychiatry, 84, 909, 10.1136/jnnp-2012-304695

Kuhle, 2015, Conversion from clinically isolated syndrome to multiple sclerosis: a large multicentre study, Mult Scler J, 21, 1013, 10.1177/1352458514568827

Tintore, 2015, Defining high, medium, and low impact prognostic factors for developing multiple sclerosis, Brain, 138, 1863, 10.1093/brain/awv105

Huss, 2016, Importance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German–Austrian retrospective multicenter study in patients with a clinically-isolated syndrome, J Neurol, 263, 2499, 10.1007/s00415-016-8302-1

Martinelli, 2017, Multiple biomarkers improve prediction of multiple sclerosis in clinically isolated syndromes, Acta Neurol Scand, 136, 454, 10.1111/ane.12761

Arrambide G, Tintore M, Espejo C, et al. The value of oligoclonal bands in the multiple sclerosis diagnostic criteria. Brain (in press).

Brownlee, 2016, Should the symptomatic region be included in dissemination in space in MRI criteria for MS?, Neurology, 87, 680, 10.1212/WNL.0000000000002975

Tintore, 2016, Contribution of the symptomatic lesion in establishing MS diagnosis and prognosis, Neurology, 87, 1368, 10.1212/WNL.0000000000003144

Filippi, 2017, Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study, Lancet Neurol

Barkhof, 1997, Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis, Brain, 120, 2059, 10.1093/brain/120.11.2059

Peterson, 2001, Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions, Ann Neurol, 50, 389, 10.1002/ana.1123

Geurts, 2008, Gray matter pathology in multiple sclerosis, Lancet Neurol, 7, 841, 10.1016/S1474-4422(08)70191-1

Brownlee, 2017, Periventricular lesions and MS diagnostic criteria in young adults with typical clinical isolated syndromes, Mult Scler J, 23, 1031, 10.1177/1352458516667565

Arrambide, 2017, Lesion topographies in multiple sclerosis diagnosis: a reappraisal, Neurology, 10.1212/WNL.0000000000004715

Balcer, 2015, Vision and vision-related outcome measures in multiple sclerosis, Brain, 138, 11, 10.1093/brain/awu335

Morris, 2009, Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis, BMJ, 339, b3016, 10.1136/bmj.b3016

Okuda, 2009, Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome, Neurology, 72, 800, 10.1212/01.wnl.0000335764.14513.1a

Forslin, 2016, Incidence of radiologically isolated syndrome: a population-based study, AJNR Am J Neuroradiology, 37, 1017, 10.3174/ajnr.A4660

Gabelic, 2014, Prevalence of radiologically isolated syndrome and white matter signal abnormalities in healthy relatives of patients with multiple sclerosis, AJNR Am J Neuroradiol, 35, 106, 10.3174/ajnr.A3653

Okuda, 2014, Radiologically isolated syndrome: 5-year risk for an initial clinical event, PLoS One, 9, e90509, 10.1371/journal.pone.0090509

Okuda, 2011, Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome, Neurology, 76, 686, 10.1212/WNL.0b013e31820d8b1d

Kantarci, 2016, Primary progressive multiple sclerosis evolving from radiologically isolated syndrome, Ann Neurol, 79, 288, 10.1002/ana.24564

Lebrun, 2012, Impact of pregnancy on conversion to clinically isolated syndrome in a radiologically isolated syndrome cohort, Mult Scler J, 18, 1297, 10.1177/1352458511435931

Lebrun, 2016, Evaluation of quality of life and fatigue in radiologically isolated syndrome, Rev Neurol (Paris), 172, 392, 10.1016/j.neurol.2016.04.004

Lebrun, 2010, Cognitive function in radiologically isolated syndrome, Mult Scler J, 16, 919, 10.1177/1352458510375707

Azevedo, 2015, Early CNS neurodegeneration in radiologically isolated syndrome, Neurol Neuroimmunol Neuroinflamm, 2, e102, 10.1212/NXI.0000000000000102

Keegan, 2016, Progressive solitary sclerosis. Gradual motor impairment from a single CNS demyelinating lesion, Neurology, 87, 1713, 10.1212/WNL.0000000000003235

Mitjana, 2014, Diagnostic value of brain chronic black holes in T1-weighted MR images in clinically isolated syndromes, Mult Scler J, 20, 1471, 10.1177/1352458514526083

Sati, 2016, The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative, Nat Rev Neurol, 12, 714, 10.1038/nrneurol.2016.166

Absinta, 2013, Seven-tesla phase imaging of acute multiple sclerosis lesions: a window into the inflammatory process, Ann Neurol, 74, 669, 10.1002/ana.23959

Kilsdonk, 2014, Morphological features of MS lesions on FLAIR* at 7T and their relation to patient characteristics, J Neurol, 261, 1356, 10.1007/s00415-014-7351-6

Sormani, 2008, Will Rogers phenomenon in multiple sclerosis, Ann Neurol, 64, 428, 10.1002/ana.21464

Thông tin
Thông tin xuất bản

The Lancet Neurology

Tập 17 Số 2

162-173

Thông tin tác giả